Capecitabine (C), oxaliplatin (OXP), and radiation (RT) in resectable esophagus cancer (EC): A phase II trial with gene expression profiling (GEP)
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: N. I. Khushalani, J. Miecznikowski, D. Wang, N. Nowak, H. Nava, M. E. Nava, W. Tan, R. Iyer, G. Yang, L. Pendyala
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2242218494
